Immunohistochemical staining of CD10 in atypical fibroxanthomas

Journal of Cutaneous Pathology

Volumn 34, Issue 5, 2007, Pages 415-419

  Hultgren, Tricia L ^a   DiMaio, Dominick J ^a,b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; FEMALE; FIBROXANTHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; SPINDLE CELL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEPRILYSIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247328977     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00635.x     Document Type: Article

References (18)

1. Helwig EB. Atypical fibroxanthoma. Tex State J Med 1963 59:664.
2. Enzinger FM, Weiss SW. Malignant fibrohistiocytic tumors. In Enzinger FM, Weiss SW. Soft tissue tumors. St. Louis, MO:Mosby, 1995 351.
3. Rizzardi C, Angiero F, Melato M. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin. Anticancer Res 2003 23:1847.
4. Zelger BG, Soyer PH, Zelger B. Giant cell atypical fibroxanthoma: does it really exist? Am J Dermatopathol 1999 21:108.
5. Pernick NL, DaSilva M, Gangi MD, Crissman J, Adsay V. "Histiocytic" markers in melanoma. Mod Pathol 1999 12:1072.
6. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Lombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma. Am J Clin Pathol 2002 117:126.
7. Ordi J, Romagosa C, Tavassoli FA, et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract. Am J Surg Pathol 2003 27:178.
8. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic for, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003 43:144.
9. Xiao SY, Wang HL, Hart J, Fleming D., Beard MR. cDNA arrays and immunohistochemical identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 2001 4:1415.
10. Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Fibrous histiocytomas. In Rosai J, Sobin LH. Tumors of the soft tissues, 3rd ed., vol. 30. Washington:Armed Forces Institute of Pathology, 2001 134.
11. Ellis GL, Langloss JM, Heffner DK, Hyams VJ. Spindle-cell carcinoma of the aerodigestive tract. Pathol Res Pract 1988 184:27.
12. Lodding P, Kindblom LG, Angervall L. Metastases of malignant melanoma simulating soft tissue sarcoma. A clinicopathological, light- and electron microscopic and immunohistochemical study of 21 cases. Virchows Arch [A] 1990 417:377.
13. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1998 15:201.
14. Mirza B, Weedon D. Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol 2005 46:235
15. Weedon D, Williamson R, Mirza B. CD10, a useful marker for atypical fibroxanthomas. Am J Dermatolpathol 2005 27:181.
16. Kanitakis J, Bourchany D, Claudy A. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 2000 20:3539.
17. Kanitakis J, Narvaez D, Claudy A. Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res 2002 12:241.
18. Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004 17:1251.